[go: up one dir, main page]

DE69934135D1 - Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen - Google Patents

Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen

Info

Publication number
DE69934135D1
DE69934135D1 DE69934135T DE69934135T DE69934135D1 DE 69934135 D1 DE69934135 D1 DE 69934135D1 DE 69934135 T DE69934135 T DE 69934135T DE 69934135 T DE69934135 T DE 69934135T DE 69934135 D1 DE69934135 D1 DE 69934135D1
Authority
DE
Germany
Prior art keywords
dosage forms
active substances
forms containing
masked active
tasty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934135T
Other languages
English (en)
Other versions
DE69934135T2 (de
Inventor
Djelila Mezaache
G Raiden
P Sanghvi
J Szedlock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valeant International Bermuda
Original Assignee
Biovail Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovail Technologies Ltd filed Critical Biovail Technologies Ltd
Application granted granted Critical
Publication of DE69934135D1 publication Critical patent/DE69934135D1/de
Publication of DE69934135T2 publication Critical patent/DE69934135T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69934135T 1998-10-30 1999-10-26 Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen Expired - Lifetime DE69934135T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/183,501 US6165512A (en) 1998-10-30 1998-10-30 Dosage forms containing taste masked active agents
US183501 1998-10-30
PCT/US1999/025059 WO2000025755A1 (en) 1998-10-30 1999-10-26 Dosage forms containing taste masked active agents

Publications (2)

Publication Number Publication Date
DE69934135D1 true DE69934135D1 (de) 2007-01-04
DE69934135T2 DE69934135T2 (de) 2007-07-26

Family

ID=22673073

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934135T Expired - Lifetime DE69934135T2 (de) 1998-10-30 1999-10-26 Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen

Country Status (8)

Country Link
US (1) US6165512A (de)
EP (1) EP1124540B1 (de)
AT (1) ATE345782T1 (de)
AU (1) AU1232600A (de)
CA (1) CA2348451C (de)
DE (1) DE69934135T2 (de)
ES (1) ES2278466T3 (de)
WO (1) WO2000025755A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057139A (en) 1995-06-29 2000-05-02 Mcneil-Ppc, Inc. Preblend of microcrystalline cellulose and lactase for making tablets
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
ATE321550T1 (de) * 1999-05-21 2006-04-15 Kissei Pharmaceutical Medizinische zusammensetzungen zur unmittelbaren freisetzung bei oraler anwendung
DE19940740A1 (de) * 1999-08-31 2001-03-01 Gruenenthal Gmbh Pharmazeutische Salze
CN1273608C (zh) * 2001-02-09 2006-09-06 荷兰联合利华有限公司 通过发酵制备一种或多种抑制素的方法
US7125564B2 (en) 2001-02-16 2006-10-24 Lavipharm Laboratories, Inc. Water soluble and palatable complexes
CN1335182A (zh) * 2001-08-08 2002-02-13 华中科技大学 胰岛素口腔喷剂及其制备工艺
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
JP2005511515A (ja) 2001-09-28 2005-04-28 マクニール−ピーピーシー・インコーポレイテッド 互いに異なる形状の内側コア及び外側シェルを有する投薬形態
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
EP1941878A1 (de) 2002-01-10 2008-07-09 Biovail Laboratories International Srl Sedative Formulierungen ohne Benzodiazepin
WO2003072021A2 (en) * 2002-02-06 2003-09-04 King Pharmaceuticals, Inc. Oral pediatric trimethobenzamide formulations and methods
US20070087981A1 (en) * 2002-02-08 2007-04-19 Lavipharm Laboratories, Inc. Water Soluble and Palatable Complexes
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US6689343B1 (en) * 2002-11-05 2004-02-10 Ultradent Products, Inc. Hemostatic and acid etch compositions containing sucralose
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
WO2005053651A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547774A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
CA2549225A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
EP1621187A1 (de) * 2004-07-26 2006-02-01 AstraZeneca AB Pharmazeutische multipartikuläre Tablettenzubereitungen und Prozess zu ihrer Herstellung
US20060039966A1 (en) * 2004-08-12 2006-02-23 Miller Bruce A Jr Dosage delivery apparatus for improving user acceptance of oral supplements and medicaments and methods for manufacturing same
EP1640401A3 (de) * 2004-09-24 2006-04-12 Clariant Produkte (Deutschland) GmbH Polyethylenglykol und Alkoholethoxylate und deren Herstellung
US7611695B2 (en) * 2004-11-15 2009-11-03 Ultradent Products, Inc. Flavored hemostatic and acid etching compositions
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PT2377557T (pt) 2004-11-24 2017-02-07 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
EP1935405A1 (de) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Im Mund zerfallende Tabletten
CA2677076C (en) * 2007-03-02 2017-09-12 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
US20110268798A1 (en) * 2009-01-16 2011-11-03 Add Advanced Drug Delivery Technologies Ltd Orally disntegrating tablets for the treatment of pain
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
RU2573293C2 (ru) 2010-03-26 2016-01-20 Филип Моррис Продактс С.А. Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов
EP2629913B1 (de) * 2010-09-20 2020-08-26 SPI Pharma, INC. Mikroeinkapselungsverfahren und -produkt
FI126168B (en) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
US9662345B2 (en) 2013-06-14 2017-05-30 Professional Compounding Centers Of America Antibiotic composition for inhalation and irrigation
EP3061501A1 (de) 2015-02-27 2016-08-31 Rottapharm Ltd. Zusammensetzung zur behandlung von akne
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
EP3302104B1 (de) * 2015-06-04 2020-09-30 Balchem Corporation Hydrierungssteuerung für cholinsalze
CA2991719C (en) * 2015-07-09 2023-07-04 Uniwell Laboratories Llc Pharmaceutical compositions
EP3117825A1 (de) 2015-07-16 2017-01-18 Rottapharm S.p.A. Orale formulierung mit berberin und morus-alba-extrakt
CN115381792A (zh) * 2015-10-02 2022-11-25 帝斯曼知识产权资产管理有限公司 新颖的包衣体系
EP3419659A1 (de) 2016-02-23 2019-01-02 The Regents of the University of Colorado, A Body Corporate Zusammensetzungen und verfahren zur herstellung und verwendung thermostabiler immunogener formulierungen mit erhöhter kompatibilität der verwendung als impfstoffe gegen ein oder mehrere pathogene
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
KR102496427B1 (ko) 2018-01-16 2023-02-06 어플라이드 머티어리얼스, 인코포레이티드 금속 산화물로 캡슐화된 약물 조성물들 및 그의 제조 방법들
CN114555031A (zh) 2019-08-27 2022-05-27 应用材料公司 用于药物防滥用制剂的气相包衣技术
TWI870622B (zh) 2020-10-02 2025-01-21 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387431A (en) * 1991-10-25 1995-02-07 Fuisz Technologies Ltd. Saccharide-based matrix
ATE130195T1 (de) * 1988-07-26 1995-12-15 Univ Rutgers Vorrichtungen und verfahren zur wachstumsförderung bei bratgeflügel.
EP0559897B1 (de) * 1990-11-30 1998-03-04 Yamanouchi Pharmaceutical Co. Ltd. Überdeckte zusammensetzung mit schneller freisetzung
CA2095776C (en) * 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
US5518551A (en) * 1993-09-10 1996-05-21 Fuisz Technologies Ltd. Spheroidal crystal sugar and method of making
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
JP4302770B2 (ja) * 1994-06-14 2009-07-29 バイオヴェイル ラボラトリーズ インターナショナル ソシエテ レスポンサビリタ リミタータ 速やかに溶解する投薬単位の製造方法及び装置並びにその製品
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
US5458823A (en) * 1994-10-28 1995-10-17 Fuisz Technologies Ltd. Method and apparatus for spinning feedstock material
US5834033A (en) * 1997-05-12 1998-11-10 Fuisz Technologies Ltd. Apparatus for melt spinning feedstock material having a flow restricting ring
US5851454A (en) * 1997-06-13 1998-12-22 Fuisz Technologies, Ltd. Spinner head having flow restricting inserts
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions

Also Published As

Publication number Publication date
WO2000025755A1 (en) 2000-05-11
CA2348451C (en) 2009-01-27
DE69934135T2 (de) 2007-07-26
CA2348451A1 (en) 2000-05-11
AU1232600A (en) 2000-05-22
EP1124540A1 (de) 2001-08-22
ATE345782T1 (de) 2006-12-15
US6165512A (en) 2000-12-26
ES2278466T3 (es) 2007-08-01
EP1124540B1 (de) 2006-11-22

Similar Documents

Publication Publication Date Title
DE69934135D1 (de) Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen
AR026745A1 (es) Composiciones de eplerenona nanoparticulada
WO2005030141A3 (en) Morinda citrifolia-based oral care compositions and methods
BG104693A (en) Fast melting oral dosage form
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DE59707812D1 (de) Opioidantagonisthaltige galenische formulierung
ATE365540T1 (de) Behandlung akuter gesundheitsstörungen durch die sublingual verabreichung einer pharmazeutischen zusammensetzung
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
TR200200065T2 (tr) Dış salgılama bozukluklarının tedavisi için terkip
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
WO2003086343A3 (en) Fast disintegrating oral dosage forms
HUP0103216A2 (hu) Gasztrointesztinális hatóanyagokat tartalmazó mukoadhezív készítmények
IL141236A0 (en) New oral formulations for 5-ht4 agonists or antagonists
BG103005A (en) Active substance-containing sedimented silicic acids
DE60322454D1 (de) Pharmazeutische Zusammensetzungen zur oralen und topischen Verabreichung
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
EA200500031A1 (ru) Быстрораспадающаяся таблетка
ITBO20010418A0 (it) Metodo e dispositivo per preparare le strutture dure dei denti all'applicazione di materiali da restauro odontoiatrici
MY141008A (en) Oral formulations of deoxypeganine and their uses
TR200100863T2 (tr) (2S,3S,5R)-2-(3,5-Diflorofenil)-3,5-dimetil-2-morfolinol ve etkili dengeleyici miktarda alginik asit içeren oral dozaj formülasyonları.
MY152490A (en) New oral formulation

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BIOVAIL LABORATORIES INTERNATIONAL S.R.L., COL, BB

8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE VON KREISLER, SELTING, WERNER ET COL

8364 No opposition during term of opposition